InsiderClue

Insider trading

Period: 120 months Stock: KYNB Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
When Periodin use
Who Role
The trade Type of trade Minimum amount Planin use Share of their own holding
Ownership What the chief executive holds
When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

1 month 12 months 120 months
465 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

Anyone CEO CFO Other officers Directors 10% owners
465 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

Any465 Buys4 Sells461 Cluster buys
465 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

Any $100K or more $1M or more $10M or more $100M or more $500M or more
465 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
Any Discretionary Scheduled (10b5-1) Not stated Not on a plan
465 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
465 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

465 decisions over 120 months
Stock
Insider
Type ?
Value ↓
Of own stake ↓
Why it stands out
KYNB KYNTRA BIO, INC.
10 Mar 2023
Conterno Enrique A Chief Executive Officer
Sold, plan not stated 2×
$638.01K 31,589 at 20.20
7.6%
KYNB KYNTRA BIO, INC.
10 Mar 2023
Eisner Mark Chief Medical Officer
Sold, plan not stated 2×
$204.80K 10,140 at 20.20
5.5%
KYNB KYNTRA BIO, INC.
10 Mar 2023
Wettig Thane Chief Commercial Officer
Sold, plan not stated 2×
$154.89K 7,669 at 20.20
6.4%
KYNB KYNTRA BIO, INC.
10 Mar 2023
Chung Christine SVP, China Operations
Sold, plan not stated 2×
$153.62K 7,606 at 20.20
2.9%
KYNB KYNTRA BIO, INC.
10 Mar 2023
Graham Juan Chief Financial Officer
Sold, plan not stated 3×
$99.21K 4,912 at 20.20
6.3%
KYNB KYNTRA BIO, INC.
8 Mar 2023
Conterno Enrique A Chief Executive Officer
Sold, plan not stated
$521.96K 24,672 at 21.16
6.5%
KYNB KYNTRA BIO, INC.
8 Mar 2023
Chung Christine SVP, China Operations
Sold, plan not stated
$176.74K 8,354 at 21.16
3.2%
KYNB KYNTRA BIO, INC.
8 Mar 2023
Eisner Mark Chief Medical Officer
Sold, plan not stated
$155.77K 7,363 at 21.16
4.3%
KYNB KYNTRA BIO, INC.
8 Mar 2023
Wettig Thane Chief Commercial Officer
Sold, plan not stated
$132.54K 6,265 at 21.16
5.7%
KYNB KYNTRA BIO, INC.
8 Mar 2023
Graham Juan Chief Financial Officer
Sold, plan not stated
$58.16K 2,749 at 21.16
3.8%
KYNB KYNTRA BIO, INC.
2 Mar 2023
Eisner Mark Chief Medical Officer
Sold, plan not stated
$25.96K 1,187 at 21.87
0.7%
KYNB KYNTRA BIO, INC.
6 Jan 2023
Conterno Enrique A Chief Executive Officer
Sold, plan not stated
$30.68K 1,538 at 19.95
0.5%
KYNB KYNTRA BIO, INC.
23 Dec 2022
Wettig Thane Chief Commercial Officer
Sold, plan not stated
$11.60K 734 at 15.80
0.8%
KYNB KYNTRA BIO, INC.
12 Dec 2022
Graham Juan Chief Financial Officer
Sold, plan not stated
$20.40K 1,407 at 14.50
2.6%
KYNB KYNTRA BIO, INC.
9 Dec 2022
Graham Juan Chief Financial Officer
Sold, plan not stated
$11.64K 781 at 14.90
1.4%
KYNB KYNTRA BIO, INC.
8 Dec 2022
Graham Juan Chief Financial Officer
Sold, plan not stated 2×
$85.50K 5,741 at 14.89
10.3%
KYNB KYNTRA BIO, INC.
8 Dec 2022
Conterno Enrique A Chief Executive Officer
Sold, plan not stated
$40.15K 2,543 at 15.79
0.8%
KYNB KYNTRA BIO, INC.
8 Dec 2022
Chung Christine SVP, China Operations
Sold, plan not stated
$17.31K 1,096 at 15.79
0.5%
KYNB KYNTRA BIO, INC.
8 Dec 2022
Wettig Thane Chief Commercial Officer
Sold, plan not stated
$6.03K 382 at 15.79
0.4%
KYNB KYNTRA BIO, INC.
15 Sep 2021
KEARNS THOMAS F JR Director
Sold, plan not stated
$151.71K 13,100 at 11.58
24.8%
KYNB KYNTRA BIO, INC.
26 Aug 2021
Wettig Thane Chief Commercial Officer
Bought
$35.74K 3,100 at 11.53
6.8%
First buy on file
KYNB KYNTRA BIO, INC.
15 Jun 2021
Cotroneo Pat SVP, Finance and CFO
Sold, plan not stated
$103.84K 4,053 at 25.62
1.4%
KYNB KYNTRA BIO, INC.
11 Mar 2021
KEARNS THOMAS F JR Director
Sold, plan not stated
$630.36K 18,000 at 35.02
10.8%
KYNB KYNTRA BIO, INC.
17 Feb 2021
Kurkijarvi Kalevi Director
Sold, plan not stated 2×
$314.38K 6,000 at 52.40
15.3%
KYNB KYNTRA BIO, INC.
19 Jan 2021
Kurkijarvi Kalevi Director
Sold, plan not stated
$260.28K 6,000 at 43.38
15.3%
KYNB KYNTRA BIO, INC.
14 Jan 2021
Kurkijarvi Kalevi Director
Sold, plan not stated
$240.20K 5,999 at 40.04
15.3%
KYNB KYNTRA BIO, INC.
28 Dec 2020
Kurkijarvi Kalevi Director
Sold, plan not stated 2×
$242.46K 6,001 at 40.40
15.3%
KYNB KYNTRA BIO, INC.
16 Dec 2020
Yu K Peony Chief Medical Officer
Sold, plan not stated
$139.39K 3,350 at 41.61
1.7%
KYNB KYNTRA BIO, INC.
15 Dec 2020
Cotroneo Pat SVP, Finance and CFO
Sold, plan not stated
$133.76K 3,068 at 43.60
1.1%
KYNB KYNTRA BIO, INC.
16 Sep 2020
Yu K Peony Chief Medical Officer
Sold, plan not stated
$147.48K 3,351 at 44.01
1.7%
KYNB KYNTRA BIO, INC.
15 Sep 2020
Cotroneo Pat SVP, Finance and CFO
Sold, plan not stated
$133.94K 3,070 at 43.63
1.1%
KYNB KYNTRA BIO, INC.
3 Sep 2020
Cotroneo Pat SVP, Finance and CFO
Sold, plan not stated
$763.85K 15,004 at 50.91
5.1%
KYNB KYNTRA BIO, INC.
3 Sep 2020
Yu K Peony Chief Medical Officer
Sold, plan not stated
$508.90K 10,000 at 50.89
4.6%
KYNB KYNTRA BIO, INC.
7 Aug 2020
Cotroneo Pat SVP, Finance and CFO
Sold, plan not stated
$1.08M 22,554 at 48.00
7.7%
KYNB KYNTRA BIO, INC.
24 Jul 2020
Yu K Peony Chief Medical Officer
Sold, plan not stated
$141.91K 3,351 at 42.35
1.6%
KYNB KYNTRA BIO, INC.
16 Jun 2020
Cotroneo Pat SVP, Finance and CFO
Sold, plan not stated
$155.86K 3,928 at 39.68
1.4%
KYNB KYNTRA BIO, INC.
11 Jun 2020
Conterno Enrique A Chief Executive Officer · indirect
Bought
$698.60K 19,800 at 35.28
248%
First buy on file
KYNB KYNTRA BIO, INC.
10 Jun 2020
Conterno Enrique A Chief Executive Officer · indirect
Bought
$290.28K 8,000 at 36.29
opened
First buy on file
KYNB KYNTRA BIO, INC.
19 Mar 2020
KEARNS THOMAS F JR Director
Sold, plan not stated
$417.07K 18,000 at 23.17
11.1%
KYNB KYNTRA BIO, INC.
19 Mar 2020
Chung Christine SVP, China Operations
Sold, plan not stated 3×
$190.28K 7,345 at 25.91
4.4%
KYNB KYNTRA BIO, INC.
18 Mar 2020
Chung Christine SVP, China Operations
Sold, plan not stated 3×
$96.80K 3,905 at 24.79
2.4%
KYNB KYNTRA BIO, INC.
16 Mar 2020
Cotroneo Pat SVP, Finance and CFO
Sold, plan not stated
$243.54K 9,239 at 26.36
3.8%
KYNB KYNTRA BIO, INC.
12 Feb 2020
Chung Christine SVP, China Operations
Sold, plan not stated 2×
$258.62K 5,625 at 45.98
4.1%
KYNB KYNTRA BIO, INC.
11 Feb 2020
Chung Christine SVP, China Operations
Sold, plan not stated
$250.20K 5,625 at 44.48
4.1%
KYNB KYNTRA BIO, INC.
10 Feb 2020
Kurkijarvi Kalevi Director
Sold, plan not stated
$256.14K 6,000 at 42.69
17.4%
KYNB KYNTRA BIO, INC.
7 Jan 2020
Chung Christine SVP, China Operations
Sold, plan not stated
$240.53K 5,625 at 42.76
4.1%
KYNB KYNTRA BIO, INC.
6 Jan 2020
Kurkijarvi Kalevi Director
Sold, plan not stated
$255.96K 6,000 at 42.66
17.4%
KYNB KYNTRA BIO, INC.
6 Jan 2020
Chung Christine SVP, China Operations
Sold, plan not stated
$241.76K 5,625 at 42.98
4.1%
KYNB KYNTRA BIO, INC.
20 Dec 2019
Cotroneo Pat SVP, Finance and CFO
Sold, plan not stated 2×
$2.72M 59,456 at 45.67
19.2%
KYNB KYNTRA BIO, INC.
17 Dec 2019
Chung Christine SVP, China Operations
Sold, plan not stated 2×
$264.24K 5,625 at 46.98
4.1%
Showing 1–50 of 465. Page 1 of 10 Older →